Correlation Between Biomarin Pharmaceutical and Prometheus Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Biomarin Pharmaceutical and Prometheus Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biomarin Pharmaceutical and Prometheus Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biomarin Pharmaceutical and Prometheus Biosciences, you can compare the effects of market volatilities on Biomarin Pharmaceutical and Prometheus Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biomarin Pharmaceutical with a short position of Prometheus Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biomarin Pharmaceutical and Prometheus Biosciences.

Diversification Opportunities for Biomarin Pharmaceutical and Prometheus Biosciences

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Biomarin and Prometheus is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Biomarin Pharmaceutical and Prometheus Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Prometheus Biosciences and Biomarin Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biomarin Pharmaceutical are associated (or correlated) with Prometheus Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Prometheus Biosciences has no effect on the direction of Biomarin Pharmaceutical i.e., Biomarin Pharmaceutical and Prometheus Biosciences go up and down completely randomly.

Pair Corralation between Biomarin Pharmaceutical and Prometheus Biosciences

If you would invest (100.00) in Prometheus Biosciences on November 9, 2024 and sell it today you would earn a total of  100.00  from holding Prometheus Biosciences or generate -100.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

Biomarin Pharmaceutical  vs.  Prometheus Biosciences

 Performance 
       Timeline  
Biomarin Pharmaceutical 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Biomarin Pharmaceutical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Biomarin Pharmaceutical is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.
Prometheus Biosciences 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Prometheus Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong fundamental indicators, Prometheus Biosciences is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.

Biomarin Pharmaceutical and Prometheus Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Biomarin Pharmaceutical and Prometheus Biosciences

The main advantage of trading using opposite Biomarin Pharmaceutical and Prometheus Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biomarin Pharmaceutical position performs unexpectedly, Prometheus Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Prometheus Biosciences will offset losses from the drop in Prometheus Biosciences' long position.
The idea behind Biomarin Pharmaceutical and Prometheus Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Other Complementary Tools

Equity Valuation
Check real value of public entities based on technical and fundamental data
Money Managers
Screen money managers from public funds and ETFs managed around the world
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital